# National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
*Name of Committee:* National Cancer Institute Initial Review Group; Subcommittee I—Career Development.
*Date:* February 10-11, 2009.
*Time:* 8 a.m. to 5 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* Doubletree Hotel Washington DC, 1515 Rhode Island Ave, Washington, DC 20005.
*Contact Person:* Sonya Roberson, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8109, Bethesda, MD 20892, 301-594-1182, *[email protected].*
*Name of Committee:* National Cancer Institute Special Emphasis Panel; Molecular Profiles in Tumors.
*Date:* February 19, 2009.
*Time:* 8 a.m. to 6 p.m.
*Agenda:* To review and evaluate contract proposals.
*Place:* National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).
*Contact Person:* Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892-8329, 301-496-7576, *[email protected].*
*Name of Committee:* National Cancer Institute Special Emphasis Panel; Innovative Strategies to Protect Radiosensitive Organs.
*Date:* February 26, 2009.
*Time:* 9:30 a.m. to 1:30 p.m.
*Agenda:* To review and evaluate contract proposals.
*Place:* National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).
*Contact Person:* Marvin L Salin, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, *[email protected].*
*Name of Committee:* National Cancer Institute Special Emphasis Panel; Innovative Technologies for Molecular Analysis of Cancer (R21).
*Date:* March 4-5, 2009.
*Time:* 8 a.m. to 5 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.
*Contact Person:* Adriana Stoica, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd, Ste 703, Room 7072, Bethesda, MD 20892-8329, 301-594-1408, *[email protected].*
*Name of Committee:* National Cancer Institute Special Emphasis Panel; Platforms for Improved Diagnosis of Cancer.
*Date:* March 16-17, 2009.
*Time:* 8 a.m. to 6 p.m.
*Agenda:* To review and evaluate contract proposals.
*Place:* Hilton Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877.
*Contact Person:* Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892-8329, 301-496-7576, *[email protected].*
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: December 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.